A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213
Bernstein, V., Ellard, S. L., Dent, S. F., Tu, D., Mates, M., Dhesy-Thind, S. K., Panasci, L., Gelmon, K. A., Salim, M., Song, X., Clemons, M., Ksienski, D., Verma, S., Simmons, C., Lui, H., Chi, K., Feilotter, H., Hagerman, L. J., Seymour, L.
Published in Breast cancer research and treatment (2018)
Published in Breast cancer research and treatment (2018)
Get full text
Journal Article
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
Biagi, J.J., Oza, A.M., ChalChal, H.I., Grimshaw, R., Ellard, S.L., Lee, U., Hirte, H., Sederias, J., Ivy, S.P., Eisenhauer, E.A.
Published in Annals of oncology (01.02.2011)
Published in Annals of oncology (01.02.2011)
Get full text
Journal Article
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer
Davidson, J.A, Cromwell, I, Ellard, S.L, Lohrisch, C, Gelmon, K.A, Shenkier, T, Villa, D, Lim, H, Sun, S, Taylor, S, Taylor, M, Czerkawski, B, Hayes, M, Ionescu, D.N, Yoshizawa, C, Chao, C, Peacock, S, Chia, S.K
Published in European journal of cancer (1990) (01.07.2013)
Published in European journal of cancer (1990) (01.07.2013)
Get full text
Journal Article
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer
Chi, K. N., Ellard, S. L., Hotte, S. J., Czaykowski, P., Moore, M., Ruether, J. D., Schell, A. J., Taylor, S., Hansen, C., Gauthier, I., Walsh, W., Seymour, L.
Published in Annals of oncology (01.04.2008)
Published in Annals of oncology (01.04.2008)
Get full text
Journal Article
A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer
Michels, J., Ellard, S.L., Le, L., Kollmannsberger, C., Murray, N., Tomlinson Guns, E.S., Carr, R., Chi, K.N.
Published in Annals of oncology (01.02.2010)
Published in Annals of oncology (01.02.2010)
Get full text
Journal Article
Preliminary safety, efficacy, and PK/PD characterization from GARNET, a phase I clinical trial of the anti–PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced MSI-H endometrial cancer
Oaknin, A., Ellard, S.L., Leath III, C., Moreno, V., Kristeleit, R., Guo, W., Lu, S., Jenkins, D., McEachern, K., Yu Jen, K., Dunlap, S., Im, E., Gilbert, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)
Hirte, H, Oza, A, Swenerton, K, Ellard, S.L, Grimshaw, R, Fisher, B, Tsao, M, Seymour, L
Published in Gynecologic oncology (01.09.2010)
Published in Gynecologic oncology (01.09.2010)
Get full text
Journal Article
Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab
Seal, M D, Speers, C H, O'Reilly, S, Gelmon, K A, Ellard, S L, Chia, S K
Published in Current oncology (Toronto) (01.08.2012)
Published in Current oncology (Toronto) (01.08.2012)
Get full text
Journal Article
935PDPreliminary safety, efficacy, and PK/PD characterization from GARNET, a phase I clinical trial of the anti-PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced MSI-H endometrial cancer
Oaknin, A, Ellard, S L, Leath III, C, Moreno, V, Kristeleit, R, Guo, W, Lu, S, Jenkins, D, McEachern, K, Yu Jen, K, Dunlap, S, Im, E, Gilbert, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
LBA51CCTG IND 232: A phase II study of durvalumab with or without tremelimumab in patients with metastatic castration resistant prostate cancer (mCRPC)
Hotte, S J, Winquist, E, Chi, K N, Ellard, S L, Sridhar, S, Emmenegger, U, Salim, M, Iqbal, N N, Canil, C, Kollmannsberger, C K, Hansen, A R, Lalani, A-K A, Gingerich, J, Finch, D, Cabanero, M, Wyatt, A W, Tu, D, Vera-Badillo, F, Seymour, L K, Smoragiewicz, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase II study of sorafenib in combination with bicalutamide in patients with chemo-naive hormone refractory prostate cancer (HRPC)
Beardsley, E. K., Ellard, S. L., Holte, S. J., North, S. A., Winquist, E., Chi, K. N.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase II study of sunitinib (SU11248) in patients (pts) with recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma - NCIC CTG IND 185
Biagi, J. J., Oza, A. M., Grimshaw, R., Ellard, S. L., Lee, U., Sederias, J., Ivy, S. P., Eisenhauer, E. A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Abstract P5-12-10: Comparison of the efficacy of tamoxifen and aromatase inhibitors on survival in adjuvant menopausal breast cancer
Chay, WY, Speers, C, Gondara, L, Tyldesley, S, Ellard, SL, Lohrisch, CA, Gelmon, KA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
P1-12-25: Evaluation of PTEN, EGFR and Ki67 Expression as Predictors of Response to a Trastuzumab-Containing Neoadjuvant Chemotherapy Regimen in a HER-2 Over-Expressing Locally Advanced Breast Cancer (LABC) Trial
Ho, J, Turashvili, G, Hayes, M, Gelmon, KA, Ellard, SL, Macpherson, N, Pansegrau, G, Chia, SK
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article